Literature DB >> 12956298

Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field.

M Dispas1, F Schynts, M Lemaire, C Letellier, E Vanopdenbosch, E Thiry, P Kerkhofs.   

Abstract

During a field trial to evaluate the efficacy of repeated vaccinations with bovine herpesvirus type 1 (BHV-1) marker vaccines, a glycoprotein E (gE)-negative BHV-1 strain was isolated from the nasal secretions of two cows, eight months after vaccination with a gE-negative live-attenuated vaccine, initially given intranasally, then intramuscularly. The strain isolated was characterised using immunofluorescence, restriction analysis and PCR. All the techniques used identified the isolated virus as a gE-negative BHV-1 phenotypically and genotypically identical to the Za strain used as a control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956298     DOI: 10.1136/vr.153.7.209

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  3 in total

1.  Bovine herpesvirus type 1 (BoHV-1) anterograde neuronal transport from trigeminal ganglia to nose and eye requires glycoprotein E.

Authors:  Mario C S Brum; Charles Coats; Rajkumari B Sangena; Allan Doster; Clinton Jones; Shafiqul I Chowdhury
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

2.  Superinfection prevents recombination of the alphaherpesvirus bovine herpesvirus 1.

Authors:  François Meurens; Frédéric Schynts; Günther M Keil; Benoît Muylkens; Alain Vanderplasschen; Pierre Gallego; Etienne Thiry
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 3.  Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.

Authors:  Richard C Condit; Anna-Lise Williamson; Rebecca Sheets; Stephen J Seligman; Thomas P Monath; Jean-Louis Excler; Marc Gurwith; Karin Bok; James S Robertson; Denny Kim; R Michael Hendry; Vidisha Singh; Lisa M Mac; Robert T Chen
Journal:  Vaccine       Date:  2016-06-23       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.